StageZero Life Sciences, DiagnoseAtHome Partner on Multicancer Blood Test
StageZero's Aristotle test uses mRNA technology to identify the molecular signatures of multiple cancer types.
Source: 360dx.com
Stay updated with breaking news from Zero Chairman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StageZero's Aristotle test uses mRNA technology to identify the molecular signatures of multiple cancer types.
The COVID-19 pandemic led to a surge in late-stage cancer diagnoses, with restrictions preventing or discouraging many from getting screened early. But an Ontario company has developed a new cancer screening test that uses blood samples, which could make it easier to detect cancers earlier.